Allergy Asthma and Clinical Immunology

Papers
(The H4-Index of Allergy Asthma and Clinical Immunology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Treatment strategies for asthma: reshaping the concept of asthma management63
Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis46
Asthma and COVID-19: a systematic review37
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report37
Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis35
Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network33
Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology32
“Immune Boosting” in the time of COVID: selling immunity on Instagram30
COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)27
Community-based interventions for childhood asthma using comprehensive approaches: a systematic review and meta-analysis27
The excess costs of childhood food allergy on Canadian families: a cross-sectional study25
Th17/Treg imbalance is associated with reduced indoleamine 2,3 dioxygenase activity in childhood allergic asthma24
Epidemiology of comorbidities and their association with asthma control23
Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren22
Relationship between Th17-mediated immunity and airway inflammation in childhood neutrophilic asthma20
Canadian food ladders for dietary advancement in children with IgE-mediated allergy to milk and/or egg19
Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma19
Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis18
Practical challenges in oral immunotherapy resolved through patient-centered care18
0.031219005584717